Clinical Trial Update: Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on CD22 CAR T-cells for B-cell lymphoma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Lymphoma
• Chronic Lymphocytic Leukemia

Drugs mentioned

• CD22-CAR T Cells

Snippet

Sponsor: Kecellitics Biotech Company Ltd | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN